Get started
Author

Paul Michael Maciocia

Observed names: Maciocia, Paul M, P M Maciocia, P. M. Maciocia, P. Maciocia, P.M. Maciocia, PM Maciocia, Paul M Maciocia, Paul M. Maciocia, Paul Maciocia
Observed institutions: University of London, University College Hospital, University College London Hospitals NHS Foundation Trust, Royal Hospital for Children, Bristol Royal Infirmary, University of Bristol, Royal Hospital for Sick Children, Autolus (United Kingdom), University College London, University of Edinburgh
ORCID: 0000-0002-9757-8073
Observed ORCID: 0000-0002-9757-8073
OpenAlex ID: A5015483375
Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies
2017 · Paul M Maciocia, Patrycja A Wawrzyniecka, et al. · Nature Medicine · 302
An APRIL-based chimeric antigen receptor for dual targeting of BCMA and TACI in multiple myeloma
2017 · Lydia Lee, Benjamin Draper, et al. · Blood · 183
PDF
Anti-CCR9 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemia
2022 · Paul M. Maciocia, Patrycja A. Wawrzyniecka, et al. · Blood · 70
PDF
Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry
2024 · Pedro Horna, Matthew J. Weybright, et al. · Blood Cancer Journal · 68
PDF
TRBC1-CAR T cell therapy in peripheral T cell lymphoma: a phase 1/2 trial
2024 · Kate Cwynarski, Gloria Iacoboni, et al. · Nature Medicine · 52
Pain assessment in the paediatric Emergency Department: whose view counts?
2003 · Paul M. Maciocia, Elizabeth M. Strachan, et al. · European Journal of Emergency Medicine · 39
Clopidogrel reduces platelet–leucocyte aggregation, monocyte activation and RANTES secretion in type 2 diabetes mellitus: Figure 1
2006 · S A Harding, J Sarma, et al. · Heart · 34
CAR T-cell therapies for T-cell malignancies: does cellular immunotherapy represent the best chance of cure?
2024 · Nicola Maciocia, Brandon Wade, et al. · Blood Advances · 32
Real‐world use of pomalidomide and dexamethasone in double refractory multiple myeloma suggests benefit in renal impairment and adverse genetics: a multi‐centre UK experience
2017 · Nicola Maciocia, Andrew Melville, et al. · British Journal of Haematology · 31
PDF
Treatment of diffuse large B‐cell lymphoma with secondary central nervous system involvement: encouraging efficacy using CNS ‐penetrating R‐ IDARAM chemotherapy
2015 · Paul Maciocia, Mohsin Badat, et al. · British Journal of Haematology · 27
PDF
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies
2024 · Mathieu Ferrari, Matteo Righi, et al. · Nature Communications · 26
PDF
Chimeric antigen receptor T cells for gamma–delta T cell malignancies
2021 · P. A. Wawrzyniecka, L. Ibrahim, et al. · Leukemia · 18
PDF
Anti-CD1a CAR T cells to selectively target T-ALL
2019 · Paul M. Maciocia, Martin A. Pule · Blood · 11
PDF
Structure Guided Engineering of Highly Specific Chimeric Antigen Receptors for the Treatment of T Cell Lymphomas
2018 · Shimobi Onuoha, Mathieu Ferrari, et al. · Blood · 10
Anti-CD21 Chimeric Antigen Receptor (CAR)-T Cells for T Cell Acute Lymphoblastic Leukaemia (T-ALL)
2021 · Nicola C Maciocia, Amy Burley, et al. · Blood · 7
Abstract 2183: Targeting TRBC1 and 2 for the treatment of T cell lymphomas
2020 · Mathieu Ferrari, Vania Baldan, et al. · Cancer Research · 6
Inflammatory Signaling in Pulmonary Arterial Hypertension: The Controversial Role of CRP, and the Search for New Therapies
2010 · Paul M. Maciocia · Cardiovascular Therapeutics · 6
Single‐centre experience of implementing physiotherapist‐led prehabilitation for chimeric antigen receptor T cell therapy
2024 · Orla McCourt, Paul Maciocia, et al. · eJHaem · 5
PDF
A Protein-Based Method to Develop Allogeneic Chimeric Antigen Receptor T-Cells
2018 · Paul Maciocia, Patrycja Wawrzyniecka, et al. · Blood · 5
Autoantibody Origins in Lupus and in Relapse Post CAR-T Therapy
2025 · Amalie Grenov, Jongwon Yoon, et al. · SSRN Electronic Journal · 3
Analysis of T-Cell Receptor Beta-Constant Region Expression for Rapid Assessment of T-Cell Clonality
2018 · Paul Maciocia, Margarida Neves, et al. · Blood · 3
A Novel Protein-Based Approach to Generate Allogeneic CAR-T Cells with Simultaneous TCR and MHC Class 1 Downregulation
2022 · Thaneswari Karpanasamy, Patrycja Wawrzyniecka, et al. · Blood · 2
Anti-CCR9 CAR-T Cells for T Acute Lymphoblastic Leukemia
2021 · Paul M Maciocia, Patrycja Wawrzyniecka, et al. · Blood · 2
A new prognostic model for myeloma patients relapsing from upfront autologous transplantation based on ISS and PFS 1
2018 · Selina J. Chavda, Paul M. Maciocia, et al. · British Journal of Haematology · 2
PDF
Targeting the T‐cell Receptor Β‐constant Domain for Immunotherapy of T‐cell Malignancies
2017 · P.M. Maciocia, P. Wawrzyniecka, et al. · Hematological Oncology · 2
PDF
Works count: 49
Citation count: 956
H-index: 12
I10-index: 14
Year
Topic
Type